12/9/2023 0 Comments Auburn journal christopher upham![]() Journal Article: Impact of landscape fire smoke exposure on patients with Asthma with or without laryngeal hypersensitivity Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study. Samaranayake, Chinthaka Bhagya, Upham, John, Tran, Khoa, Howard, Luke S, Nguyen, Sean, Lwin, Myo, Anderson, James, Wahi, Sudhir, Price, Laura C, Wort, Stephen, Li, Wei, McCabe, Colm and Keir, Gregory J (2023). Journal Article: Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study (2023).īiologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Thomas, Dennis, McDonald, Vanessa M., Stevens, Sean, Harvey, Erin S., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Gillman, Andrew, Hew, Mark, Hodge, Sandra, James, Alan, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Marks, Guy, Peters, Matthew, Radhakrishna, Naghmeh, Reynolds, Paul N., Rimmer, Janet, Sivakumaran, Pathmanathan, Upham, John W., Wark, Peter, Yang, Ian A. Journal Article: Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients He contributed to Clinical Practice Guidelines for the use of omalizumab and mepolizumab in Australia and he was part of the working group that prepared a web-based Severe Asthma Toolkit for the Severe Asthma CRE. John's research will inform best use of influenza vaccination in COPD, and guide the use of conjugate vaccines to improve immunity to Haemophilus in Indigenous children. His research has provided new treatment options for severe asthma, and guided the appropriate length of antibiotic treatment for Indigenous children with pneumonia, protracted bacterial bronchitis and bronchiectasis. He has been a member of multiple advisory boards to pharmaceutical companies, both international and national (AstraZeneca, GSK, Novartis, Nycomed, Boehringer-Ingelheim, Mundipharma, Menarini), and has provided advice to the Pharmaceutical Benefits Advisory Committee. He has played a leadership role in organising and co-chairing three recent national symposia on severe asthma to facilitate research collaboration, build research and clinical capacity, and improve models of care for severe asthma. John is currently the President (2021-22) of the Thoracic Society of Australia and Zealand and is a key member of the NHMRC funded Centre of Research Excellence (CRE) in Asthma Treatable Traits. In recognition of his international standing and influence in the field, he was elected Fellow of the American Academy of Allergy, Asthma & Immunology (2004) and the Thoracic Society of Australia and New Zealand (2015). John was regularly an invited (9x), plenary (3x) and Chair (9x) at national and international conferences in the last 5 years. He currently holds NHMRC grants of $7.5 million, including $2.96 million as CIA. John has been awarded 8 NHMRC Project grants (4 as CIA in the last 5 years), 2 NHMRC CRE (“Closing the gap in Indigenous Lung Health” and “Severe Asthma”), and 1 NHMRC Development Grant. In the last 10 years, he has secured over $24 million in research funding. His research has international reach with citations in 80 countries (Scopus Dec 2018). His publications have been cited in >20 different subject areas, demonstrating translation to fields other than Medicine. Moreover, 21.5% of publications are in the top 10% of most-cited publications worldwide (field-weighted). Since 2009, he has 112 publications (1st/senior author on 45%) with a Field-Weighted Citation Impact of 2.03. John is highly influential in his field, with > 195 publications, > 5,400 citations and an H index of 46. John Upham is a clinical scientist and physician with longstanding research interests in the immunological basis of asthma and chronic lung disease, the role of dendritic cells in allergy and virus infections of the lung, and the development of novel approaches to severe asthma treatment.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |